This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Why Software ETFs are Soaring
by Neena Mishra
Software companies are growing fast as they benefit from rising global corporate spending on software solutions.
Tech ETFs in Focus on Oracle's Mixed Bag Q1 Results
by Sweta Killa
ETFs with the highest allocation to this software giant look to be big movers this week and in the next, as investors digest its scores and views.
Forget FAANGs, Focus on Software ETFs
by Zacks Equity Research
Software ETFs are performing exceedingly well this year and have more to offer going forward.
The Zacks Analyst Blog Highlights: First Trust Technology, Invesco DWA, iShares North American, ARK Innovation and AdvisorShares
by Zacks Equity Research
The Zacks Analyst Blog Highlights: First Trust Technology, Invesco DWA, iShares North American, ARK Innovation and AdvisorShares
5 Tech ETFs Leading the Surge This Week
by Sweta Killa
The S&P 500 and Nasdaq surged to record highs for the fourth consecutive day driven by the surge in the information technology sector.
Market-Beating, Top-Ranked ETFs of the Longest Bull Market
by Sweta Killa
The U.S. bull market is now the longest ever, stretching 3,453 days or nine and-a-half years. We have presented a bunch of top performing ETFs of the longest bull market.
5 Hot Tech ETFs & Stocks Leading the Market Rally
by Sweta Killa
We have highlighted the five best performing tech ETFs and stocks that have hit new highs in the latest trading session and are expected to outperform in the months ahead.
Broadcom to Acquire CA: Tech ETFs in Focus
by Sweta Killa
The announced acquisition has put the spotlight on a few technology ETFs focusing on either semiconductor or software.
The Zacks Analyst Blog Highlights: Virtus LifeSci Biotech Clinical, SPDR S&P Biotech, iShares North American Tech-Software, PowerShares Dynamic Semiconductors and Restoration Hardware
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Virtus LifeSci Biotech Clinical, SPDR S&P Biotech, iShares North American Tech-Software, PowerShares Dynamic Semiconductors and Restoration Hardware
5 Technology ETFs in Focus as Oracle Cloud Disappoints
by Sweta Killa
While Oracle beat the Zacks Consensus Estimate for revenues and earnings, it disappointed investors with a bleak outlook.